BROADCASTS.com

b'Informatics systems used by research scientists today have significant limitations, since they come from many vendors, use different data formats, and were developed with various UI standards. These limitations create barriers to accessing and integrating heterogeneous, siloed research data in a meaningful way to facilitate innovation and collaboration. In this session, Accenture and Merck discuss the expanded capabilities and benefits-for drug discovery organizations and software providers-of a newly launched research platform that gives the research science world a highly elastic, cloud infrastructure with a single UI and advanced computing power that accelerates drug discovery activities and enables competitive differentiation. This session is brought to you by AWS partner, Accenture.'